Skip to main content
ConductScienceScienceDex

Katy Rezvani

NIH Rank #4189
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11681365Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology

NIH Funding · FY2025

Linked Award Amount
$2.7M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#4,189
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Katy Rezvani. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Katy Rezvani as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA303579-01R01
    Advancing next-generation CAR-NK therapies targeting CD5 positive T cell malignancies to the clinic
    UT MD Anderson Cancer Center
    $1.8M
    award amount
  • 5R01CA280827-03R01
    Next Generation Engineered NK Cells for Lymphoma Patients after CD19 CAR-T Cell Failure.
    UT MD Anderson Cancer Center
    $370.6K
    award amount
  • 5R01CA288617-02R01
    TROP2-Directed CAR-NK Cells for the Immunotherapy of Pancreatic Cancer
    UT MD Anderson Cancer Center
    $370.6K
    award amount
  • 5P50CA281701-03P50
    The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
    UT MD Anderson Cancer Center
    $75.9K
    award amount

Award organization

Organizations that administered FY2025 awards listing Katy Rezvani as a PI.

FY2025 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #4189
  6. 2025
    Entered Top 25% Nationally
    Ranked #4189
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Katy Rezvani.

Rafet Basar
UT MD Anderson Cancer Center
7
shared awards
May Daher
UT MD Anderson Cancer Center
4
shared awards
Hind Rafei
UT MD Anderson Cancer Center
3
shared awards
Anil K Sood
UT MD Anderson Cancer Center
2
shared awards
Jinsong Liu
UT MD Anderson Cancer Center
2
shared awards
Robert C Bast
UT MD Anderson Cancer Center
2
shared awards
Rugang Zhang
UT MD Anderson Cancer Center
2
shared awards
Ying Yuan
UT MD Anderson Cancer Center
2
shared awards
Eleonora Dondossola
UT MD Anderson Cancer Center
1
shared award
Jeremy Leon Ramdial
UT MD Anderson Cancer Center
1
shared award

Explore further

Find collaborators for Katy Rezvani

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →